Alba Redondo

662 total citations
16 papers, 501 citations indexed

About

Alba Redondo is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Alba Redondo has authored 16 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Alba Redondo's work include Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Mesenchymal stem cell research (4 papers). Alba Redondo is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers) and Mesenchymal stem cell research (4 papers). Alba Redondo collaborates with scholars based in Spain, Netherlands and Sweden. Alba Redondo's co-authors include Fermín Sánchez‐Guijo, Sandra Muntión, Rebeca Ortega, Ángel Hernández‐Hernández, Consuelo del Cañizo, Luis Ignacio Sánchez‐Abarca, Concepción Rodríguez, Silvia Preciado, Teresa Lopes Ramos and Guillermo López-Ruano and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Alba Redondo

15 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Redondo Spain 9 227 227 105 98 93 16 501
Cristiana Lavazza Italy 15 300 1.3× 192 0.8× 52 0.5× 84 0.9× 103 1.1× 33 573
Karlien Pieters Belgium 13 262 1.2× 331 1.5× 128 1.2× 110 1.1× 128 1.4× 15 618
Séverine Lecourt France 17 321 1.4× 302 1.3× 154 1.5× 53 0.5× 194 2.1× 22 795
Xiuli Cong United States 10 206 0.9× 221 1.0× 56 0.5× 70 0.7× 59 0.6× 14 499
Amélia G. Araújo Brazil 14 232 1.0× 199 0.9× 102 1.0× 78 0.8× 87 0.9× 29 571
Oksana Kehoe United Kingdom 13 252 1.1× 195 0.9× 28 0.3× 82 0.8× 96 1.0× 21 632
Soraya Tabera Spain 7 206 0.9× 460 2.0× 164 1.6× 88 0.9× 187 2.0× 10 676
Bo‐Ra Son South Korea 6 211 0.9× 381 1.7× 41 0.4× 94 1.0× 174 1.9× 9 633
Shengqin Ye China 5 240 1.1× 432 1.9× 49 0.5× 69 0.7× 227 2.4× 6 639
Stefanie Liedtke Germany 7 235 1.0× 362 1.6× 48 0.5× 59 0.6× 200 2.2× 12 552

Countries citing papers authored by Alba Redondo

Since Specialization
Citations

This map shows the geographic impact of Alba Redondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Redondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Redondo more than expected).

Fields of papers citing papers by Alba Redondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Redondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Redondo. The network helps show where Alba Redondo may publish in the future.

Co-authorship network of co-authors of Alba Redondo

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Redondo. A scholar is included among the top collaborators of Alba Redondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Redondo. Alba Redondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Martı́n, Alejandro, Mónica Baile, Guillermo Rodríguez‐Domínguez, et al.. (2023). Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: A phase 2 study from GELTAMO. British Journal of Haematology. 203(2). 202–211.
2.
Jiménez, Tamara, Irene Aires‐Mejía, Rebeca Ortega, et al.. (2019). Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity. British Journal of Haematology. 187(1). 93–104. 15 indexed citations
3.
Blanco, Juan F., Eva M. Villarón, David Pescador, et al.. (2019). Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up. Stem Cell Research & Therapy. 10(1). 63–63. 47 indexed citations
4.
Martin-Rufino, Jorge D., et al.. (2018). Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease). Stem Cell Research & Therapy. 9(1). 150–150. 12 indexed citations
5.
Thielen, Frederick W., Hedwig M. Blommestein, Liesbeth E.M. Oosten, et al.. (2018). Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model. European Journal Of Haematology. 101(5). 676–683. 5 indexed citations
6.
Sánchez‐Abarca, Luis Ignacio, Beatriz Rosón, Alba Redondo, et al.. (2017). Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis. PLoS ONE. 12(8). e0182470–e0182470. 15 indexed citations
7.
Ramos, Teresa Lopes, Luis Ignacio Sánchez‐Abarca, Alba Redondo, et al.. (2017). HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?. Oncotarget. 8(17). 28187–28202. 10 indexed citations
8.
Ramos, Teresa Lopes, Luis Ignacio Sánchez‐Abarca, Sandra Muntión, et al.. (2016). MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Cell Communication and Signaling. 14(1). 2–2. 246 indexed citations
9.
Ramos, Teresa Lopes, Luis Ignacio Sánchez‐Abarca, Beatriz Rosón, et al.. (2016). Extracellular Vesicles Play an Important Role in Intercellular Communication Between Bone Marrow Stroma and Hematopoietic Progenitor Cells in Myeloproliferative Neoplasms. Blood. 128(22). 1957–1957. 5 indexed citations
10.
Xicoy, Blanca, Jennifer Kaivers, Ulrich Germing, et al.. (2016). Analysis of Transfusion Dependency Development and Disease Evolution in Patients with MDS with 5q- and without Transfusion Needs at Diagnosis. Blood. 128(22). 3180–3180. 1 indexed citations
11.
Martı́n, Alejandro, Alba Redondo, Iván Dlouhy, et al.. (2016). Lenalidomide in combination with R‐ESHAP in patients with relapsed or refractory diffuse large B‐cell lymphoma: a phase 1b study from GELTAMO group. British Journal of Haematology. 173(2). 245–252. 19 indexed citations
12.
Sánchez, Lydia, Alba Redondo, Óscar Blanco, et al.. (2014). Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?. Annals of Hematology. 94(4). 609–616. 7 indexed citations
13.
Paíno, Teresa, María Eugenia Sarasquete, Bruno Paiva, et al.. (2014). Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138++ and CD138low Subpopulations in Multiple Myeloma Cell Lines. PLoS ONE. 9(3). e92378–e92378. 20 indexed citations
14.
15.
Sánchez‐Guijo, Fermín, Teresa Caballero‐Velázquez, Olga López‐Villar, et al.. (2014). Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(10). 1580–1585. 96 indexed citations
16.
Cramer, Paula, et al.. (1983). [Cerebro-meningeal hemorrhage in the initial stage of idiopathic thrombocytopenic purpura].. PubMed. 40(2). 105–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristiana Lavazza Breakdown of academic impact, for papers by Karlien Pieters Breakdown of academic impact, for papers by Séverine Lecourt Breakdown of academic impact, for papers by Xiuli Cong Breakdown of academic impact, for papers by Amélia G. Araújo Breakdown of academic impact, for papers by Oksana Kehoe Breakdown of academic impact, for papers by Soraya Tabera Breakdown of academic impact, for papers by Bo‐Ra Son Breakdown of academic impact, for papers by Shengqin Ye Breakdown of academic impact, for papers by Stefanie Liedtke
Rankless by CCL
2026